iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Purchased by Summit Investment Advisors Inc.

featured-image

Summit Investment Advisors Inc. increased its position in iRhythm Technologies, Inc. (NASDAQ:IRTC – Free Report) by 6.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,271 shares of the company’s stock after acquiring an additional 210 shares during the [...]

Summit Investment Advisors Inc. increased its position in iRhythm Technologies, Inc. ( NASDAQ:IRTC – Free Report ) by 6.

9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,271 shares of the company’s stock after acquiring an additional 210 shares during the period. Summit Investment Advisors Inc.



’s holdings in iRhythm Technologies were worth $295,000 as of its most recent SEC filing. Other institutional investors and hedge funds have also made changes to their positions in the company. R Squared Ltd purchased a new stake in iRhythm Technologies during the 4th quarter worth about $45,000.

Van ECK Associates Corp increased its holdings in shares of iRhythm Technologies by 41.3% during the 4th quarter. Van ECK Associates Corp now owns 554 shares of the company’s stock worth $50,000 after buying an additional 162 shares during the last quarter.

Nisa Investment Advisors LLC raised its holdings in shares of iRhythm Technologies by 166.6% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,037 shares of the company’s stock worth $94,000 after purchasing an additional 648 shares during the period.

KBC Group NV lifted its position in iRhythm Technologies by 45.1% during the fourth quarter. KBC Group NV now owns 1,319 shares of the company’s stock valued at $119,000 after buying an additional 410 shares in the last quarter.

Finally, Wilmington Savings Fund Society FSB acquired a new stake in shares of iRhythm Technologies in the third quarter valued at about $119,000. iRhythm Technologies Price Performance NASDAQ IRTC opened at $100.96 on Monday.

The company has a 50 day simple moving average of $105.45 and a 200-day simple moving average of $93.61.

The company has a debt-to-equity ratio of 9.00, a current ratio of 6.27 and a quick ratio of 6.

12. iRhythm Technologies, Inc. has a 52-week low of $55.

92 and a 52-week high of $128.52. The firm has a market capitalization of $3.

17 billion, a price-to-earnings ratio of -27.74 and a beta of 1.45.

Analysts Set New Price Targets A number of analysts recently issued reports on IRTC shares. Needham & Company LLC lifted their price target on shares of iRhythm Technologies from $125.00 to $138.

00 and gave the stock a “buy” rating in a research note on Friday, February 21st. The Goldman Sachs Group lifted their price objective on shares of iRhythm Technologies from $91.00 to $124.

00 and gave the company a “neutral” rating in a research report on Monday, February 24th. StockNews.com raised iRhythm Technologies from a “sell” rating to a “hold” rating in a research note on Monday, February 24th.

Wells Fargo & Company raised their price objective on shares of iRhythm Technologies from $86.00 to $104.00 and gave the company an “equal weight” rating in a research note on Friday, February 21st.

Finally, Truist Financial upped their price target on shares of iRhythm Technologies from $111.00 to $145.00 and gave the company a “buy” rating in a report on Friday, February 21st.

Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, iRhythm Technologies presently has an average rating of “Moderate Buy” and an average target price of $119.73.

Read Our Latest Stock Analysis on IRTC iRhythm Technologies Company Profile ( Free Report ) iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. Recommended Stories Want to see what other hedge funds are holding IRTC? Visit HoldingsChannel.

com to get the latest 13F filings and insider trades for iRhythm Technologies, Inc. ( NASDAQ:IRTC – Free Report ). Receive News & Ratings for iRhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRhythm Technologies and related companies with MarketBeat.

com's FREE daily email newsletter ..